ARCHIVES

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

This article is from The Cancer Letter archive.

Vol. 31 No. 22 | June 3, 2005

Download PDF Visit The Full Archive

Related Articles

DCCP Payback System Saving $1 Million Year

December 3, 1982

In Brief: FDA commissioner Kessler To Resign, Says His Goals Were Accomplished

November 29, 1996

In Brief: Wyeth-Ayerst To donate hormone Replacement Therapy To NIH For Women’s Health Initiative

April 23, 1993

In Brief: New Cancer control Program On Schedule; NCI Expects 10-15CCRU, 30-40 CCSP Applications

July 2, 1982

NCI Seeks 150 Advocates For Advice On Plans, Policies.

March 2, 2001

CPSC Relies On NCI Findings For New Policy

July 21, 1978